Table 3.
Definition | No. of participants | Person-years | All-cause mortality | Death Due to Cancer | Death Due to CVD | Other-cause death | |
---|---|---|---|---|---|---|---|
ADA criteria | |||||||
By FPG level | |||||||
No. of deaths by prediabetes status | 96 | 52 | 20 | 24 | |||
Normoglycemia | FPG <100 mg/dL | 38,338 | 214,604 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) |
Prediabetes | FPG 100–125 mg/dL | 20,385 | 112,034 | 1.51 (1.12–2.05) | 2.32 (1.46–3.71) | 1.18 (0.62–2.23) | 1.03 (0.61–1.77) |
By HbA1c | |||||||
No. of deaths by prediabetes status | 64 | 33 | 13 | 18 | |||
Normoglycemia | HbA1c <5.7% | 47,224 | 265,413 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) |
Prediabetes | HbA1c 5.7–6.4% | 11,657 | 62,129 | 1.58 (1.15–2.17) | 1.93 (1.21–3.08) | 1.03 (0.52–2.03) | 1.60 (0.90–2.87) |
WHO/IEC criteria | |||||||
By FPG level | |||||||
No. of deaths by prediabetes status | 37 | 21 | 8 | 8 | |||
Normoglycemia | FPG <110 mg/dL | 53,017 | 296,004 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) |
Prediabetes | FPG 110–125 mg/dL | 5,706 | 30,634 | 1.68 (1.15–2.43) | 2.19 (1.30–3.67) | 1.40 (0.63–3.10) | 1.22 (0.57–2.63) |
By HbA1c | |||||||
No. of deaths by prediabetes status | 24 | 15 | 3 | 6 | |||
Normoglycemia | HbA1c <6.0% | 54,145 | 302,894 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) |
Prediabetes | HbA1c 6.0–6.4% | 4,736 | 24,648 | 1.18 (0.76–1.84) | 1.73 (0.97–3.10) | 0.45 (0.13–1.50) | 1.13 (0.48–2.70) |
Values in bold are statistically significant. Model was adjusted for age (year, continuous), sex, worksite, BMI (kg/m2), smoking status (never smoker, former smoker, or current smoker), hypertension (yes or no), and dyslipidemia (yes or no). Ref., reference.